| The C1q receptors: focus on gC1qR/p33 (C1qBP, p32, HABP-1) 1 B Ghebrehiwet, BV Geisbrecht, X Xu, AG Savitt, EIB Peerschke Seminars in Immunology 45, 101338, 2019 | 71 | 2019 |
| Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar TN Soe, Y Wu, MW Tun, X Xu, Y Hu, Y Ruan, AYN Win, MH Nyunt, ... Parasites & vectors 10, 1-6, 2017 | 46 | 2017 |
| Seasonal dynamics and microgeographical spatial heterogeneity of malaria along the China–Myanmar border Y Hu, G Zhou, Y Ruan, M Lee, X Xu, S Deng, Y Bai, J Zhang, J Morris, ... Acta tropica 157, 12-19, 2016 | 38 | 2016 |
| SARS-CoV-2 exacerbates COVID-19 pathology through activation of the complement and kinin systems AG Savitt, S Manimala, T White, M Fandaros, W Yin, H Duan, X Xu, ... Frontiers in Immunology 12, 767347, 2021 | 37 | 2021 |
| Microgeographic heterogeneity of border malaria during elimination phase, Yunnan Province, China, 2011–2013 X Xu, G Zhou, Y Wang, Y Hu, Y Ruan, Q Fan, Z Yang, G Yan, L Cui Emerging infectious diseases 22 (8), 1363, 2016 | 19 | 2016 |
| Process improvement for fermentation coupling with foam separation: a convenient strategy for cell recycle D Zhang, K Dong, D Xu, H Zheng, Z Wu, X Xu Asia‐Pacific Journal of Chemical Engineering 10 (3), 466-475, 2015 | 13 | 2015 |
| Inhibition of the complement alternative pathway by chemically modified DNA aptamers that bind with picomolar affinity to factor B X Xu, C Zhang, DT Denton, D O’Connell, DW Drolet, BV Geisbrecht The Journal of Immunology 206 (4), 861-873, 2021 | 12 | 2021 |
| Associations among soil-transmitted helminths, G6PD deficiency and asymptomatic malaria parasitemia, and anemia in schoolchildren from a conflict zone of northeast Myanmar W Zeng, P Malla, X Xu, L Pi, L Zhao, X He, Y He, LJ Menezes, L Cui, ... The American Journal of Tropical Medicine and Hygiene 102 (4), 851, 2020 | 11 | 2020 |
| AI is a viable alternative to high throughput screening: a 318-target study Scientific reports 14 (1), 7526, 2024 | 9 | 2024 |
| Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl) Pyridine-3-Carboximidamide and Chemical Analogs X Xu, TJ Herdendorf, H Duan, DL Rohlik, S Roy, H Zhou, H Alkhateeb, ... The Journal of Immunology 212 (4), 689-701, 2024 | 3 | 2024 |
| gC1qR/C1qBP/HABP-1: structural analysis of the trimeric core region, interactions with a novel panel of monoclonal antibodies, and their influence on binding to FXII Y Zhang, AJ Vontz, EM Kallenberger, X Xu, NT Ploscariu, KX Ramyar, ... Frontiers in Immunology 13, 887742, 2022 | 3 | 2022 |
| Group B Streptococcus Surface Protein β: Structural Characterization of a Complement Factor H–Binding Motif and Its Contribution to Immune Evasion X Xu, AL Lewis Marffy, A Keightley, AJ McCarthy, BV Geisbrecht The Journal of Immunology 208 (5), 1232-1247, 2022 | 2 | 2022 |
| Structural/functional analysis of complement proteins and inhibitions X Xu Kansas State University, 2022 | | 2022 |
| Structural and Interaction Insight in Streptococcal beta C Proteins X Xu, N van Sorge, S van der Lans, E van Woudenbergh, J van Strijp, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Expression, purification, and characterization of a human complement component C3 analog that lacks the C-terminal C345c domain KX Ramyar, X Xu, NM White, A Keightley, BV Geisbrecht Journal of immunological methods 473, 112633, 2019 | | 2019 |
